THE FIRST REPORT OF A CROTALID ENVENOMATION IN A DOMESTICATED FERRET (MUSTELA FURO) AND SUCCESSFUL TREATMENT WITH A NOVEL F(AB′)2 ANTIVENOM

2018 ◽  
Vol 49 (2) ◽  
pp. 497-500
Author(s):  
Ariel I. Loredo ◽  
Jenny E. Bauman ◽  
Raegan J. Wells
Keyword(s):  
Successful Treatment ◽  
First Report ◽  
Mustela Furo

scholarly journals Successful Treatment of Transient Central Diabetes Insipidus following Traumatic Brain Injury in a Dog

2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Catriona Croton ◽  
Sarah Purcell ◽  
Andrea Schoep ◽  
Mark Haworth
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Diabetes Insipidus ◽  
Successful Treatment ◽  
Serum Sodium ◽  
Rapid Onset ◽  
Central Diabetes Insipidus ◽  
The Other ◽  
Clinical Progression ◽  
First Report

An 11-year-old female spayed Maltese presented comatose, half an hour after vehicular trauma, and was treated for traumatic brain injury and pulmonary contusions. The dog developed severe hypernatremia within six hours of presentation, which responded poorly to the administration of five percent dextrose in water. As central diabetes insipidus was suspected, desmopressin was trialled and resolution of hypernatremia was achieved six days later. Transient trauma-induced central diabetes insipidus has been described previously in two dogs; in the first, serum sodium concentrations were evaluated three days after injury and the other developed hypernatremia seven days after injury. To the authors’ knowledge, this is the first report of rapid onset, transient, and trauma-induced central diabetes insipidus in a dog that encompasses the complete clinical progression of the syndrome from shortly after injury through to resolution.

scholarly journals Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia

2019 ◽  
Vol 3 (21) ◽  
pp. 3333-3336 ◽  
Author(s):  
Fares Alsawah ◽  
Lydia Benitez ◽  
Sarah Choi ◽  
Bernard Marini ◽  
Anthony Perissinotti ◽  
...  
Keyword(s):  
T Cell ◽  
Successful Treatment ◽  
Potential Treatment ◽  
Prolymphocytic Leukemia ◽  
First Report ◽  
Therapeutic Alternative ◽  
Key Points

Key Points This is the first report of successful treatment of therapy-resistant leptomeningeal T-PLL with intrathecal alemtuzumab. Intrathecal alemtuzumab is a potentially safe and efficacious therapeutic alternative for treatment of leptomeningeal T-PLL.

scholarly journals Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature

2017 ◽  
Vol 4 (2) ◽  
Author(s):  
Samantha E. Jacobs ◽  
Deborah Saez-Lacy ◽  
Walter Wynkoop ◽  
Thomas J. Walsh
Keyword(s):  
Case Report ◽  
Adverse Effects ◽  
Invasive Aspergillosis ◽  
Successful Treatment ◽  
Marked Improvement ◽  
Allergic Bronchopulmonary Aspergillosis ◽  
Primary Therapy ◽  
Review Of The Literature ◽  
First Report

Abstract Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.

Successful treatment of SUNCT syndrome with divalproex sodium extended-release

2010 ◽  
pp. 34-35
Author(s):  
Raimundo Pereira da Silva Neto ◽  
Kelson James Almeida
Keyword(s):  
Successful Treatment ◽  
Extended Release ◽  
Divalproex Sodium ◽  
Conjunctival Injection ◽  
First Report ◽  
Sunct Syndrome ◽  
Treatment Patient

Introduction: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) syndrome is a primary rare headache. This syndrome is known to be refractory to pharmacotherapy. Various treatments have been tried for SUNCT syndrome, generally of little benefit. Objective: To report a case of SUNCT syndrome who was successfully treated with divalproex sodium extended-release (DVPX ER) and to review the literature about of drugs used in this treatment. Patient and Method: The authors report a case of a 61 year-old man, suffering from SUNCT syndrome, who was successfully treated with DVPX ER. We review the literature about several categories of drugs that are used in the treatment to this syndrome. Conclusion: SUNCT syndrome is clinically well identified, but it is poorly treated. This is first report of SUNCT syndrome responsive to DVPX ER.

Pott’s puffy tumour: an unusual presentation and management

2001 ◽  
Vol 115 (6) ◽  
pp. 497-499 ◽  
Author(s):  
Maheshwar ◽  
Harris ◽  
Al-Mokhthar ◽  
Evans
Keyword(s):  
Rare Disease ◽  
Successful Treatment ◽  
Clinical Presentation ◽  
Maxillary Sinusitis ◽  
Clinical Entity ◽  
Unusual Presentation ◽  
Rare Clinical Entity ◽  
Frontal Sinusitis ◽  
First Report

Pott’s puffy tumour is a rare clinical entity in this era of antibiotics. It is usually seen as a complication of frontal sinusitis. This is the first report of Pott’s puffy tumour presenting as a complication of maxillary sinusitis. This is also the first reported case of Pott’s puffy tumour treated with debridement and gentamicin beads. We discuss the clinical presentation and successful treatment of this rare disease.

Desperate times, desperate measures: successful use of chemotherapy in treatment of haemophagocytic lymphohistiocytosis (HLH) due to disseminated histoplasmosis

2020 ◽  
Vol 13 (9) ◽  
pp. e235144
Author(s):  
Sunny Rajendra Kumar Singh ◽  
Kannan Thanikachalam ◽  
Vijayalakshmi Donthireddy
Keyword(s):  
Adult Patient ◽  
Antifungal Therapy ◽  
Successful Treatment ◽  
Immune Suppression ◽  
Haemophagocytic Lymphohistiocytosis ◽  
First Report ◽  
Disseminated Histoplasmosis

We describe a case of haemophagocytic lymphohistiocytosis (HLH) secondary to disseminated histoplasmosis, which was treated with chemotherapy in addition to standard antifungal therapy. While HLH in the setting of infections is very well described, its treatment in this setting is controversial, with some physicians treating only the underlying infection, whereas others using immune suppression in addition to antimicrobials. To the best of our knowledge, this is the first report documenting the successful treatment of an adult patient with HLH due to disseminated histoplasmosis using etoposide chemotherapy after initial antifungal therapy failed to show improvement.

scholarly journals Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases

2020 ◽  
Vol 11 (8) ◽  
pp. 2339-2342
Author(s):  
Xiaoyan Si ◽  
Hanping Wang ◽  
Xiaotong Zhang ◽  
Mengzhao Wang ◽  
Yan You ◽  
...  
Keyword(s):  
Successful Treatment ◽  
Inflammatory Myofibroblastic Tumor ◽  
First Report ◽  
Pulmonary Inflammatory Myofibroblastic Tumor
Sign in / Sign up

Export Citation Format

Share Document